Niagen Bioscience (NAGE) Profit After Tax (2010 - 2026)

Niagen Bioscience (NAGE) has 17 years of Profit After Tax data on file, last reported at $6.3 million in Q1 2026.

• On a quarterly basis, Profit After Tax rose 24.79% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $18.6 million, a 31.78% increase from a year earlier, with the FY2025 full-year figure at $17.4 million, up 103.3% from the prior year.
• Profit After Tax for Q1 2026 stood at $6.3 million, up from $4.1 million in the prior quarter.
• Over the last five years, Profit After Tax for NAGE reached as high as $7.2 million in Q4 2024 and fell as low as -$7.7 million in Q1 2022.
• Historically, Profit After Tax has averaged $630705.9 across 5 years, with a median of -$15000.0 in 2024.
• On a YoY basis, Profit After Tax climbed as much as 24160.0% in 2025 and fell as far as 43.14% in 2025.
• Year by year, Profit After Tax stood at -$1.4 million in 2022, then jumped by 108.04% to $114000.0 in 2023, then surged by 6197.37% to $7.2 million in 2024, then tumbled by 43.14% to $4.1 million in 2025, then surged by 54.78% to $6.3 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were $6.3 million in Q1 2026, $4.1 million in Q4 2025, and $4.6 million in Q3 2025.